# HALO: Halozyme Therapeutics, Inc.

- Industry: Biological Products, (No Diagnostic Substances)
- Current price: $112.45
- Price updated: Sep 19, 2026
- Total congressional trades: 1
- Politicians trading: 1
- Last traded: Mar 24, 2025
- Source: https://tryglasshouse.ai/companies/HALO.md

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

# Congressional trading history

- Page: 1 of 1
- Results: 1 of 1
- Pagination query parameter: `page`

## 1. Gilbert Ray Cisneros, Jr.

- Member: Democrat, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Mar 24, 2025, disclosed Apr 7, 2025
- Market context: $64.02 at trade, $112.45 current (+75.65%)
- Politician: https://tryglasshouse.ai/politicians/C001123.md
- Record: https://tryglasshouse.ai/trades/6d1c47b2-45fa-4c87-be35-bc2b5a66c7d5.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.